Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users

Addiction

Volumn 99, Issue 9, 2004, Pages 1157-1166

  Tucker, Thamizan ^a   Fry, Craig L ^a,b   Lintzeris, Nick ^c,d   Baldwin, Simon ^a   Ritter, Alison ^a   Donath, Susan ^a   Whelan, Greg ^e  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

Brief behavioural intervention; Hepatitis C virus; Injecting drug use; Randomized controlled trial

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; EDUCATION; FEMALE; FOLLOW UP; GROUP PSYCHOLOGY; HEALTH BEHAVIOR; HEPATITIS C; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BEHAVIOR THERAPY; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 4544294192     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00809.x     Document Type: Article

References (42)

1. Abraham, C., Sheeran, P. & Obell, S. (1998) Can social cognitive models contribute to the effectiveness of HIV-preventive behavioural interventions? A brief review of the literature and a reply to Joffe (1996, 1997) and Fife-Schaw (1997). British Journal of Medical Psychology, 71, 297-310.
2. Aitken, C. K., Kerger, M. & Crofts, N. (2002) Peer-delivered hepatitis C testing and counselling: a means of improving the health of Injecting drug users. Drug and Alcohol Review, 21, 33-37.
3. Australian Injecting and Illicit Drug Users' League (2000a) Liver First. National Hepatitis C Education/Prevention Program. ACT: AIVL. Available at: http://www.aivl.org.au/ resources.html.
4. Australian Injecting and Illicit Drug Users' League (2000b) Safer Injecting. National Hepatitis C Education/Prevention Program. ACT: AIVL. Available at: http://www.aivl.org.au/ resources.html.
5. Australian National Council on AIDS, Hepatitis C and Related Diseases (2002) Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research.
6. van Beek, I., Dwyer, R., Dore, G. J., Luo, K. & Kaldor, J. M. (1998) Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ, 317, 433-437.
7. Bien, T. H., Miller, W. R. & Tonigan, J. S. (1993) Brief interventions for alcohol problems: a review. Addiction, 88, 315-335.
8. Broers, B., Junet, C., Bourquin, M., Deglon, J. J., Perrin, L. & Hirschel, B. (1998) Prevalence and incidence of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS, 12, 2059-2066.
9. Chick, J., Lloyd, G. & Crombie, E. (1984) Counselling problem drinkers in medical wards: a controlled study. BMJ, 290, 965-967.
10. Cohen, J. (1992) A power primer. Psychological Bulletin, 112, 155-159.
11. Copeland, J., Swift, W., Roffman, R. & Stephens, R. (2001) A randomized controlled trial of brief cognitive-behavioural interventions for cannabis use disorder. Journal of Substance Abuse Treatment, 21, 55-64.
12. Crofts, N. & Aitken, C. K. (1997) Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-95. Medical Journal of Australia, 167, 17-20.
13. Crofts, N., Jolley, D., Kaldor, J., van Beek, I. & Wodak, A. (1997a) Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health. 51, 692-697.
14. Crofts, N., Nigro, L., Oman, K., Stevenson, E. & Sherman, J. (1997b) Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction, 92, 999-1005.
15. Des Jarlais, D. C. (2001) Hepatitis C among drug users: déjà vu all over again? American Journal of Public Health, 91, 21-22.
16. Dunn, C., Deroo, L. & Rivara, F. P. (2001) The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction, 96, 1725-1742.
17. Dwyer, R., Fry, C., Carruthers, S., Bolleter, A., Dolan, K., Donald, A., Byrne, J. & Loxley, W. (2002) The Australian Blood-Borne Virus Risk and Injecting Drug Use Study (ABRIDUS): a National Study of Hepatitis C Risk Practices and Contexts in Melbourne, Perth and Sydney. Monograph no. 3. Fitzroy: Turning Point Alcohol & Drug Centre Inc.
18. Fishbein, M. (2000) The role of theory in HIV prevention. AIDS Care, 12, 273-278.
19. Fry, C. L. & Lintzeris, N. (2003) Psychometric properties of the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction, 98, 171-178.
20. Fry, C., Rumbold, G. & Lintzeris, N. (1998) The Blood Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) Administration and Procedures Manual. Melbourne: Turning Point Alcohol & Drug Centre Inc.
21. Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S. & Alexander, E. R. (2001) Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42-46.
22. Heather, N. (1989) Psychology and brief interventions. British Journal of Addiction, 84, 357-370.
23. Heather, N. (1995a) Interpreting the evidence on brief interventions for excessive drinkers: the need for caution. Alcohol, 30, 287-296.
24. Heather, N. (1995b) Treatment approaches to alcohol problems. WHO Regional Publications European Series, 65, 1-201.
25. Heather, N., Robertson, I., MacPherson, B., Allsop, S. & Fulton, A. (1987) Effectiveness of a controlled drinking self-help manual: one-year follow-up results. British Journal of Clinical Psychology, 26, 279-287.
26. Hepatitis C Council of Victoria (2000) Impact: Hepatitis C Information, 2nd edn. Victoria: Hepatitis C Council of Victoria.
27. Hurley, S. F., Jolley, D. J. & Kaldor, J. M. (1997) Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349, 1797-1800.
28. Ladewig, D. (2001) A reduction in HIV positive and an increase in hepatitis C positive subjects in methadone maintenance treatments. Swiss Medical Weekly, 131, 422.
29. Lang, E., Engelander, M. & Brooke, T. (2000) Report of an integrated brief intervention with self defined problem cannabis users. Journal of Substance Abuse Treatment, 19, 111-116.
30. MacDonald, M. A., Wodak, A. D., Dolan, K. A., van Beek, L. Cunningham, P. H. & Kaldor, J. M. (2000) Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-97. Medical Journal of Australia, 172, 57-61.
31. Moyer, A. & Finney, J. W. (2002) Randomized versus nonrandomized studies of alcohol treatment: participants, methodological features and post treatment functioning. Journal of Studies on Alcohol. 63, 542-550.
32. National Centre in HIV Epidemiology and Clinical Research (2002) HIV/AIDS. Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report. Sydney: National Centre in HIV Epidemiology and Clinical Research.
33. Poikolainen, K. (1999) Effectiveness of brief interventions to reduce alcohol intake in primary health care populations: a meta-analysis. Preventative Medicine. 28, 503-509.
34. Russell, M. A. H., Wilson, C., Taylor, C. & Baker, C. D. (1979) Effect of general practitioners' advice against smoking. BMJ. 2, 231-235.
35. Saunders, B., Wilkinson, C. & Phillips, M. (1995) The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction, 90, 415-424.
36. Selvey, L. A., Denton, M. & Plant, A. J. (1997) Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. Australian and New Zealand Journal of Public Health, 21, 102-104.
37. Simmonds, P., Holmes, E. C., Cha, T. A., Chan, S. W., McOmish, F., Irvine, B., Beall, E., Yap, P. L., Kolberg, J. & Urdea, M. S. (1993) Classification of hepatitis C virus into six major geno-types and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology, 74, 2391-2399.
38. Stephens, R. S., Roffman, R. A. & Curtin, L. (2000) Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898-908.
39. Thiede, H., Hagan, H. & Murrill, C. S. (2000) Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. Journal of Urban Health, 77, 331-345.
40. Thompson, P. R. & Locarnini, S. A. (2001) Virology and molecular virology of the Hepatitis C virus. In: Crofts, N., Dore, G. & Locarnini, S. eds. Hepatitis C: An Australian Perspective. pp. 15-31. Melbourne: IP Communications.
41. Topp, L., Kaye, S., Bruno, R., Longo, M., Williams, P., O'Reilly, B., Fry, C., Rose, G. & Darke, S. (2002) Australian Drug Trends 2001: Findings of the Illicit Drug Reporting System (IDRS). Monograph no. 48. Sydney: National Drug and Alcohol Research Centre. University of NSW
42. Wallace, P., Cutler, S. & Haines, A. (1988) Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. BMJ, 297, 663-668.